Found Weight Loss Review 2026: GLP-1 Pricing, Coaching & Who It’s Right For
What Found Actually Is
Found (joinfound.com) is a US telehealth weight management platform founded in 2019. Its model is deliberately different from pure medication-delivery platforms: Found pairs prescription weight loss medication with dedicated health coaching, community features, and structured behavioral content. The company's philosophy is that sustainable weight loss requires addressing the behavioral, psychological, and environmental factors that contribute to weight gain — not just prescribing medication.
This approach is clinically grounded. Major obesity treatment guidelines consistently recommend combining pharmacotherapy with lifestyle intervention for better long-term outcomes. Found built their platform around this evidence. The question for each patient is whether Found's specific coaching model matches their needs and whether the bundled cost is worth it for the behavioral support they'll actually use.
Found's medication options extend beyond GLP-1 to include metformin, bupropion-naltrexone (Contrave), topiramate, and other pharmacotherapies. This broad formulary is a genuine advantage for patients whose clinical profiles make non-GLP-1 options more appropriate. The flip side: patients who already know they want semaglutide or tirzepatide may find Found's multi-medication evaluation process adds a step that focused platforms skip.
Found's Coaching Model: Genuine Strength
Found's coaching is the most important thing to understand about the platform — it's what separates Found from every other GLP-1 telehealth provider and it's what justifies Found's premium pricing. After enrollment, patients are matched with a dedicated health coach who provides regular check-ins, personalized guidance on nutrition, exercise, sleep, and stress, and accountability through the Found app via messaging.
The coaches are trained in behavior change methodology — identifying obstacles like emotional eating patterns, sedentary work environments, or the psychological challenges that accompany significant weight loss. For patients who have struggled with weight management on their own and benefit from structured external accountability, this coaching can genuinely change outcomes. It's not a chatbot or AI assistant; it's a trained human coach with personalized knowledge of your situation.
Found also provides peer community features — the ability to connect with other patients sharing similar journeys. Community engagement is a well-documented factor in behavior change maintenance, and Found has invested in this infrastructure. For patients who respond to social support and accountability, Found's community adds a dimension that medication-only platforms simply don't offer.
The honest caveat: Found's coaching is valuable only if you use it. Patients who are self-motivated, have existing support systems, or primarily need medication access are paying $99–$149/month for a service they won't engage with meaningfully. If that describes you, the coaching premium is overhead rather than value.
Found Pricing: The True Monthly Cost
Found True Monthly Cost — Verified June 2026
Found's pricing structure is more complex than platforms with single all-in rates. The membership fee is charged whether you're prescribed a $20/month medication (metformin) or a $199/month compounded GLP-1 — it's a flat overhead on top of medication. For patients seeking specifically GLP-1 therapy, this creates an effective total that runs $228–$348+/month, significantly above Luma Health's $197/month flat all-inclusive rate. Verify current Found pricing directly at joinfound.com — their rates and plan tiers change periodically.
Found Pros & Cons
- ✓ Dedicated human health coach — personalized behavioral accountability
- ✓ Founded 2019 — multi-year operating history, established platform
- ✓ Broad medication formulary — GLP-1, metformin, bupropion-naltrexone, more
- ✓ Community features — peer support for motivation and accountability
- ✓ Providers evaluate full metabolic picture — not just GLP-1 eligibility
- ✓ Evidence-based behavior change methodology
- ✓ Good fit for patients who genuinely benefit from coaching structure
- ✗ Mandatory membership fee adds $99–$149/mo on top of medication costs
- ✗ Effective GLP-1 total ~$228–$348+/mo — higher than most alternatives
- ✗ Pharmacy not prominently named — cannot independently verify before enrolling
- ✗ May prescribe non-GLP-1 medication even if you specifically wanted GLP-1
- ✗ Pricing complexity makes it hard to compare costs at a glance
- ✗ Coaching premium adds no value for self-motivated, medication-primary patients
Found vs the GLP-1 Market — Cost Comparison
| Provider | Sema/Mo (effective) | Annual (sema) | Coaching | Pharmacy Named |
|---|---|---|---|---|
| Henry Meds | ~$89–$145 (annual) | ~$1,740/yr | None | No |
| Ro Body | ~$145–$229 | ~$1,740–$2,748/yr | Async only | Ro-owned |
| ★ Luma Health | $197 flat | $2,364/yr | None | VialsRX TX#35264 ✓ |
| Found | ~$228–$348+ effective | ~$2,736–$4,176+/yr | ✓ Dedicated coach | Not named |
| Noom Med | ~$181–$279 effective | ~$2,172–$3,348/yr | Noom app | No |
| Sequence/WW Clinic | ~$122–$194 effective | ~$1,464–$2,328/yr | WW coaching | No |
The cost comparison shows Found is the most expensive compounded GLP-1 option in the market when you include the membership fee. Sequence/WW Clinic ($122–$194/mo effective) and Henry Meds (~$89–$145/mo annual) are both less expensive and also include coaching or program infrastructure. Luma Health at $197/mo flat is medication-only — no coaching — but all-inclusive with named pharmacy. If you want coaching alongside medication at lower cost than Found, Sequence/WW is worth evaluating first.
Who Should Choose Found vs Luma Health
Choose Found If...
- ○ You want dedicated human coaching with personalized behavioral accountability — and will actively use it
- ○ You've tried GLP-1 medication alone and struggled with adherence, habits, or emotional eating patterns
- ○ You want a provider to evaluate you across multiple medication options — not just GLP-1
- ○ Peer community support and social accountability matter to your weight loss success
- ○ You're comfortable paying $228–$348+/mo for a comprehensive program
★ Choose Luma Health If...
- ✓ You want GLP-1 medication access without a mandatory coaching overhead ($99–$149/mo)
- ✓ You want pharmacy named publicly before enrolling — VialsRX TX#35264, verify at pharmacy.texas.gov
- ✓ You want $197/mo flat sema regardless of dose — no tier changes, no membership fee
- ✓ You are self-motivated and have your own behavioral support structure
- ✓ You want to switch from Found and continue at your current GLP-1 dose without re-titration
$197/mo flat semaglutide. No membership fee. No coaching overhead. VialsRX TX #35264 — verifiable before you pay. All 50 states. Cancel anytime.
Start With Luma Health →Frequently Asked Questions
Is Found weight loss legitimate in 2026?
Yes. Found is a legitimate, established US telehealth weight management platform with a multi-year operating history dating to 2019. Their providers are licensed clinicians, their compounding pharmacy partners operate under 503A sterile compounding standards, and their behavioral coaching model is grounded in evidence-based obesity treatment guidelines. Found is not a fly-by-night operation — it is one of the more established compounded GLP-1 telehealth providers in the market. The primary criticism of Found is not legitimacy but cost structure: the mandatory membership fee makes Found significantly more expensive than medication-only alternatives for patients who specifically want GLP-1 therapy.
How much does Found weight loss cost per month?
Found's pricing structure includes two components: a base membership fee of approximately $99–$149/month (covers coaching, community access, app, and provider consultations), plus the cost of whatever medication is prescribed. For patients prescribed compounded semaglutide, the medication adds approximately $129–$199/month depending on dose — bringing the effective monthly total to approximately $228–$348 or more. Patients prescribed less expensive medications like metformin pay significantly less for the medication component. Always verify current pricing directly at joinfound.com before enrolling — pricing changes periodically.
Does Found prescribe semaglutide and tirzepatide?
Yes, Found prescribes both compounded semaglutide and tirzepatide as part of their GLP-1 medication menu, subject to clinical eligibility and current availability. Found's providers evaluate each patient's full health profile before prescribing — they may recommend GLP-1 therapy or, depending on the clinical assessment, may recommend a different medication pathway (metformin, bupropion-naltrexone, or others). If you have a strong preference for semaglutide or tirzepatide specifically, communicate this clearly during your Found intake — though the provider's clinical assessment will ultimately determine the prescription.
Is Found's coaching worth the extra cost?
For the right patient — yes. Found's dedicated human coaching model adds genuine value for patients who benefit from external accountability, structured behavioral support, and peer community engagement. Major obesity treatment guidelines recommend combining medication with lifestyle intervention, and Found's coaching is a real implementation of this evidence-based approach. The honest self-assessment question: will you actively engage with your health coach at least weekly, use the community features, and work through the behavioral content? If yes, the coaching premium is clinically justified. If you're self-motivated, have existing support systems, or primarily need medication access with solid clinical oversight, you're paying $99–$149/month for a service you won't use — in which case a medication-focused platform provides better value.
Can I switch from Found to Luma Health without restarting my GLP-1 dose?
Yes. Complete Luma Health's intake at start.mylumahealth.com with your current semaglutide or tirzepatide weekly dose while you still have 2–3 weeks of Found medication remaining. Wasef Health, PC prescribes at your current dose — no re-titration from the beginning. Wait for VialsRX shipping tracking confirmation before initiating your Found cancellation. When canceling Found, cancel both the medication subscription and any separate coaching or membership subscription to avoid continued billing. STEP 4 clinical data confirms that treatment continuity protects your weight loss results — the goal is no gap between your last Found dose and your first VialsRX dose.
How does Found compare to Noom Med?
Both Found and Noom Med are bundled coaching-plus-medication platforms that charge more than medication-only alternatives because they include behavioral support infrastructure. Found's coaching is more personalized — a dedicated human coach vs Noom's app-based psychology content. Found's effective total ($228–$348+/mo) is higher than Noom Med's ($181–$279/mo effective) at most tiers. Found's medication formulary is broader than Noom Med's. For patients who want coaching alongside medication, Found offers more intensive human support but at higher cost; Noom Med offers a proven behavioral methodology at lower cost but without dedicated human coaching. For patients who want just medication without behavioral overhead, Luma Health ($197/mo flat) is less expensive than both.
What medications does Found prescribe besides GLP-1?
Found's formulary includes several weight loss pharmacotherapy options beyond GLP-1: metformin (which has modest weight loss benefits and addresses insulin resistance at very low cost), bupropion-naltrexone combination (Contrave, which targets appetite through neurological pathways different from GLP-1), topiramate (an anticonvulsant with weight-suppressing effects), and potentially other medications depending on your clinical profile. This flexibility is a genuine advantage for patients who are not GLP-1 candidates or want to explore non-GLP-1 options. For patients who specifically want semaglutide or tirzepatide, Found's multi-medication approach means the provider assessment may recommend something other than GLP-1 — which is clinically sound but may not align with your treatment preference.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed 33755728
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023;389:2221–2232. PubMed 37952131
- Jensen MD, et al. AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. Circulation. 2014;129(25 Suppl 2):S102–S138. AHA Journals
- U.S. Food & Drug Administration. Human Drug Compounding — Section 503A. FDA.gov — 503A Compounding
- Found. Weight Loss Program Overview. joinfound.com
- KFF. 2024 Employer Health Benefits Survey. kff.org — 2024 Employer Survey
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- Texas State Board of Pharmacy. License Verification — VialsRX #35264. pharmacy.texas.gov